Pune, India -- (SBWire) -- 06/27/2018 --Transplant Diagnostics Market – Overview
Transplant surgeries have observed a significant uptick in recent years due to increased detection of diseases that lead to organ failure. This development has increased the growth rate experienced by transplant diagnostics. Market concentrated reports associated with the healthcare industry amid others recently have been made available by Market Research Future which issues reports on this industry. The market for transplant diagnostics is expected to develop at an encouraging CAGR of 7.2% in the duration of the forecast period.
Get Exclusive Sample Copy of Transplant Diagnostics Market spread across 80 Premium Pages, 10+ and Supported with Full TOC, is Available @ https://www.marketresearchfuture.com/sample_request/1324 .
The escalation in the detection of chronic diseases has increased the need to test whether the recipients can accept the transplant easily in case transplants are required. Lungs, liver, kidney are among the most commonly donated organs that have to be tested for compatibility with the host body. Diseases such as diabetes, renal failures, and coronary heart diseases are among a few of the chief causes fuelling the growth of the transplant diagnostic market at an increased pace. However, increased cost of transplants and lack of access to high quality medical resources is expected to restrain the market's growth in the forecast period.
Industry Segments:
The market for transplant diagnostics is segmented on the basis of products into reagent, instrument, software and services. The technology basis of segmentation of the market includes molecular assay and non-molecular assay. The non-molecular segment is further segmented into mixed lymphocyte culture and serological assay. The molecular assay segment is additionally segmented into PCR based and sequenced base. The application based segment of the market consists of kidney, lungs, heart, liver, and other. On the basis of method type, the market comprises of post-transplant screening and pre-transplant screening. Finally, the end user segmentation consists of transplants centers, hospitals, research laboratories and other.
Detailed Regional Analysis:
Africa, Middle East, Americas, Europe and Asia Pacific are the regions that are being covered in the regional analysis of the transplant diagnostics market. The America market controls the transplant diagnostics market globally as per the region wise segmentation of the market. Growing demand for cutting-edge techniques, diagnostic tools, and increased healthcare expenditure are the major factors for the development of the Americas region. The European region is the next largest transplant diagnostics market which is trailed by the Asia Pacific region. A large population base suffering from chronic diseases is the main driving factor for the Asia Pacific market.
Ask any Queries to Experts about Niche Segments, Requires Regional Data and Top Players @ https://www.marketresearchfuture.com/enquiry/1324 .
Global Competitive Analysis:
The market development by competitors encompasses strong risk management strategies which will positively influence the market. The competitors in the market are persistently trying to establish leading market positions through new policies and strategies. The experienced management in the companies functioning in the market are making business models which can bring about a fruitful phase of development. The key trends and players have established a positive tone for development. The competitors in the market are trying to succeed commercially by ensuring demand and supply are in balance. The momentum of the market's growth has altered the competitive background of the market. The contenders in the market are also leveraging their competitive advantages to secure their growth in the market.
F. Hoffman-La Roche Ltd. (Switzerland), Immucor Transplant Diagnostics, Inc (US), Becton Dickinson and Company (US), Abbott Laboratories Inc (US), CareDx (US), Omixon Ltd. (UK), bioMérieux S.A. (France), Bio-Rad Laboratories, Inc. (US),QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), Immucor, Inc. (US), GenDx (Netherlands), Illumina, Inc. (U.S.), Affymetrix, Inc (US) and Linkage Biosciences (US).
Industry Updates:
TAI Diagnostics which is US based company and develops non-invasive test to monitor patients' health after they've got heart transplants, has scheduled to initiate selling their test early next year. They have generated about $13 million from their investors so far. The company is presently raising more money to supplement its $8.3 million Series A funding round. The extension could bring TAI's total outside financing to $21 million, the startup's test measures levels of cell-free DNA, genetic material released by the transplant recipient's new heart that can enter the bloodstream, to assess whether they are in danger of rejecting the organ.
TOC of Transplant Diagnostics Market Research Report- Global Forecast Till 2023:
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
TOC CONTINUED….
Get Stunning Discount @ https://www.marketresearchfuture.com/check-discount/1324 .
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Transplant Diagnostics Market 2018; 7.2% CAGR to Initiate High Growth Possibilities: By Technology Non-Molecular Assay, Molecular Assay: Topmost Players – Says MRFR